RNA vs AAPL: Which Stock is Better?
Side-by-side comparison of Atrium Therapeutics, Inc. Common Stock and Apple Inc in 2026
RNA
Atrium Therapeutics, Inc. Common Stock
$14.25
AAPL
Apple Inc
$325.13
Key Metrics Comparison
| Metric | RNA | AAPL | Winner |
|---|---|---|---|
| Market Cap | $217.50M | $3.83T | AAPL |
| P/E Ratio | N/A | 34.84 | AAPL |
| EPS (TTM) | $N/A | $7.47 | AAPL |
| Revenue Growth | 0.0% | 7.9% | AAPL |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze RNA
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is RNA or AAPL a better investment?
Comparing RNA and AAPL: Atrium Therapeutics, Inc. Common Stock has a market cap of $217.50M while Apple Inc has $3.83T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between RNA and AAPL?
RNA (Atrium Therapeutics, Inc. Common Stock) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: RNA or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: RNA or AAPL?
AAPL has higher revenue growth at 7.9% vs 0.0% for RNA.
Which company is more profitable: RNA or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to 0.0% for RNA.
Which is the larger company: RNA or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.83T compared to $217.50M for RNA.
Should I buy RNA or AAPL in 2026?
Both RNA and AAPL have investment merit. RNA trades at $14.25 while AAPL trades at $325.13. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between RNA and AAPL stock?
Key differences: Market Cap ($217.50M vs $3.83T), P/E Ratio (N/A vs 34.8x), Revenue Growth (0.0% vs 7.9%), Gross Margin (0.0% vs 46.9%).
Should I buy RNA or AAPL in 2026?
The choice between RNA and AAPL depends on your investment goals. AAPL shows higher revenue growth (7.9%). AAPL has better margins (46.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between RNA and AAPL?
RNA (Atrium Therapeutics, Inc. Common Stock) has a market cap of $217.50M, while AAPL (Apple Inc) has a market cap of $3.83T. AAPL is the larger company by market value.